insights_auto
Why is SCNI down १०.३८%?
Dive Deeperchevron_right
SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
US$ ०.६१
arrow_downward
-१०.३८%(-०.०७१) 1D
अक्टोबर २१, १३:५३:०४ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
US$ ०.६९
High
US$ ०.६९
Low
US$ ०.५७
Mkt. cap
१८.५३ लाख
Avg. vol.
४४.३६ लाख
Volume
१.५० लाख
52-wk high
US$ १५.५०
52-wk low
US$ ०.५७
EPS
-US$ २.८०
Beta
२.१३
Shares outstanding
७.०७ लाख
No. of employees
४५
Open
US$ ०.६९
High
US$ ०.६९
Low
US$ ०.५७
Mkt. cap
१८.५३ लाख
Avg. vol.
४४.३६ लाख
Volume
१.५० लाख
52-wk high
US$ १५.५०
52-wk low
US$ ०.५७
EPS
-US$ २.८०
Beta
२.१३
Shares outstanding
७.०७ लाख
No. of employees
४५
News stories
From web sources and news partners
Investing.com
·
१ दिन पहिले
Scinai secures CDMO deal, raises $5.3M in financing
PR Newswire
·
१ दिन पहिले
Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing
Benzinga
·
१ दिन पहिले
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR